semaglutide compound deaths Novo Nordisk CEO Warns of Linked to Compounded Compounded Tirzepatide Weight Loss Program

doi: 10.3389/fmed.2025.1462145 Received 09 July 2024 Accepted 14 March 2025 Published 26 March 2025 Volume 12 - 2025 Edited by Juan Carlos Mayo, University of Oviedo, Spain Reviewed by Pedro Gonzalez-Menendez, University of Oviedo, Spain Yao Luo, Sichuan University, China Zilong Zhao, University of Texas MD Anderson Cancer Center, United States Updates Copyright 2025 Li, Deng, Jiang, Shi, Xu and Liu

Organic Solvents (DMSO, DMF): Highly hydrophobic peptides or those that form aggregates may require an organic co-solvent

Cost has been one of the biggest barriers to treatment, with many patients unable to access these medications because insurance coverage is limited and out-of-pocket prices remain high

Weight loss contributes in increasing the GLP-1 levels leading to improved glucose control in Type-2 Diabetes

Petri KCC, Ingwersen SH, Flint A, Zacho J, Overgaard RV